|
ADAM17 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.154000E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.713400E-01 |
| Normal-vs-Stage2 |
1.113640E-01 |
| Normal-vs-Stage3 |
5.309500E-02 |
| Normal-vs-Stage4 |
1.411220E-01 |
| Stage1-vs-Stage2 |
1.073390E-01 |
| Stage1-vs-Stage3 |
5.231700E-02 |
| Stage1-vs-Stage4 |
1.401370E-01 |
| Stage2-vs-Stage3 |
4.264600E-01 |
| Stage2-vs-Stage4 |
5.730000E-01 |
| Stage3-vs-Stage4 |
8.749200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.747220E-01 |
| Normal-vs-AfricanAmerican |
2.042200E-02 |
| Normal-vs-Asian |
2.885800E-01 |
| Caucasian-vs-AfricanAmerican |
1.955420E-01 |
| Caucasian-vs-Asian |
8.477400E-01 |
| AfricanAmerican-vs-Asian |
7.814600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.345800E-01 |
| Normal-vs-Female |
3.409400E-04 |
| Male-vs-Female |
3.389400E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.665200E-01 |
| Normal-vs-Extreme_Weight |
4.857000E-01 |
| Normal-vs-Obese |
2.362400E-02 |
| Normal-vs-Extreme_Obese |
7.706600E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.002200E-01 |
| Normal_Weight-vs-Obese |
1.245790E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.959800E-01 |
| Extreme_Weight-vs-Obese |
7.444100E-03 |
| Extreme_Weight-vs-Extreme_Obese |
4.280200E-01 |
| Obese-vs-Extreme_Obese |
1.973800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.334200E-02 |
| Normal-vs-Age(41-60Yrs) |
5.518300E-03 |
| Normal-vs-Age(61-80Yrs) |
8.952400E-01 |
| Normal-vs-Age(81-100Yrs) |
8.115800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.356560E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.512000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.381700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.135900E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.814780E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.453700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.335200E-01 |
| Normal-VS-Type2 PRCC |
8.934800E-01 |
| Normal-VS-KIRP CIMP |
6.918900E-03 |
| Normal-VS-Unclassified PRCC |
1.773580E-02 |
| Type1 PRCC-VS-Type2 PRCC |
6.549800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.562200E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.008400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.121100E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.337900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.566440E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.970600E-01 |
| Normal-vs-N1 |
9.075900E-03 |
| Normal-vs-N2 |
2.320600E-01 |
| N0-vs-N1 |
8.216400E-03 |
| N0-vs-N2 |
2.241000E-01 |
| N1-vs-N2 |
9.297600E-01 |
|
|
